AIM ImmunoTech Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 1.99 M | $393,763 | 0.00% | 3.45% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 698,267 | $138,257 | 0.00% | 1.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 464,016 | $91,905 | 0.00% | 0.80% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 260,479 | $51,575 | 7.10% | 0.45% |
| STATE STREET CORP | 02/14/2025 | 173,103 | $34,274 | 0.00% | 0.30% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 171,000 | $33,858 | 11.76% | 0.30% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 71,305 | $14,118 | 100.00% | 0.12% |
| XTX TOPCO LTD | 02/13/2025 | 49,212 | $9,744 | -25.32% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 38,040 | $7,532 | 100.00% | 0.07% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 36,658 | $7,000 | -64.11% | 0.06% |
| SEACREST WEALTH MANAGEMENT, LLC | 01/14/2025 | 35,063 | $6,942 | 0.00% | 0.06% |
| HRT FINANCIAL LP | 02/14/2025 | 31,648 | $6,000 | -8.91% | 0.05% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 20,000 | $3,960 | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 14,703 | $2,911 | -3.66% | 0.03% |
| BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 13,389 | $2,373 | 100.00% | 0.02% |
| COMMUNITY BANK, N.A. | 02/11/2025 | 13,226 | $2,512 | 0.00% | 0.02% |
| D.B. ROOT & COMPANY, LLC | 01/17/2025 | 12,050 | $2,386 | 0.00% | 0.02% |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 01/17/2025 | 11,777 | $2,332 | 0.00% | 0.02% |
| CI PRIVATE WEALTH, LLC | 02/10/2025 | 10,100 | $2,000 | 1.00% | 0.02% |
| HB WEALTH MANAGEMENT, LLC | 01/15/2025 | 10,000 | $1,980 | 100.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,000 | $270 | 0.00% | 0.00% |
| HOEY INVESTMENTS, INC | 02/12/2025 | 1,000 | $198 | 0.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 864 | $171 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 400 | $79 | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 02/13/2025 | 170 | $33 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 150 | $30 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 138 | $28 | 2.22% | 0.00% |
| HUNTINGTON NATIONAL BANK | 02/12/2025 | 57 | $11 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 27 | $6 | 100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 21 | $4 | 0.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AIM ImmunoTech Inc. institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of AIM ImmunoTech Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.99 M
BlackRock Funding, Inc. /DE: 698,267
GEODE CAPITAL MANAGEMENT, LLC: 464,016
RENAISSANCE TECHNOLOGIES LLC: 260,479
STATE STREET CORP: 173,103
Verition Fund Management LLC: 171,000
8.06% of AIM ImmunoTech Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.46 M shares in the last 24 months. This purchase volume represents approximately $1.37 M in transactions.